By Dr Matthew Gibson

Conference Abstracts

Rogers C; Gibson M; Kern JS; Martin LK; Robertson SJ; Su JC; Daniel BS; Murrell DF, 2021, 'A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, Vol. 141, pp. S28 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000641872800157&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gibson M; Rogers CL; Murrell DF, 2021, 'Successful dapsone therapy in inherited Epidermolysis Bullosa', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rogers CL; Gibson M; Kern JS; Martin L; Robertson S; Daniel BS; Su JC; Murrell DF, 2021, 'Which outcome measures are the best for clinical trials in Epidermolysis Bullosa?', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 110 - 111, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rogers CL; Gibson M; Kern JS; Martin L; Robertson S; Daniel BS; Su JC; Murrell DF, 2020, 'WHICH OUTCOME MEASURES ARE THE BEST FOR CLINICAL TRIALS IN EPIDERMOLYSIS BULLOSA?', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page